Clinical Trial Update: The Effect of Botulinum Toxin A In Patients With Excessive Gingival Display With And Without Zinc Supplementation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Botulinum Toxin A in patients with Excessive Gingival Display, with and without zinc supplementation; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Gingival Display

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Cairo University | Conditions: Excessive Gingival Display | Phase 3 | Status: COMPLETED